Prescription of glucocorticoids in patients with rheumatoid arthritis in Germany;Verordnung von glucocorticoiden bei rheumatologisch betreuten patienten mit rheumatoider arthritis in Deutschland

Zeitschrift fur Rheumatologie

Volumn 64, Issue 3, 2005, Pages 149-154

  Thiele, K ^a   Buttgereit, F ^b   Huscher, D ^a   Zink, A ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anti osteoporotic drug therapy; DMARDs; Glucocorticoid induced osteoporosis; National Database of the German Collaborative Arthritis Centers; NSAIDs coxibs

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; VITAMIN D;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; AWARENESS; CLINICAL TRIAL; DATA BASE; DISEASE SEVERITY; DRUG EFFECT; FREQUENCY ANALYSIS; GERMANY; HUMAN; LOW DRUG DOSE; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; OSTEOPOROSIS; PRESCRIPTION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK ASSESSMENT; SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; DRUG UTILIZATION; GERMANY; GLUCOCORTICOIDS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; REGISTRIES; RHEUMATOLOGY;

EID: 19944422130     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-005-0719-3     Document Type: Article

References (27)

1. Saag KG (2001) Resolved: Low-dose glucocorticoids are neither safe nor effective for the long-term treatment of rheumatoid arthritis. Arthritis Rheum 45(5):468-471
2. Conn DL (2001) Resolved: Low-dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis. Arthritis Rheum 45(5): 462-467
3. Kirwan JR (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 333(3):142-146
4. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC et al (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350(9074):309-318
5. Landewe RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM et al (2002) COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 46(2):347-356
6. Svensson B, Albertsson K, Boonen A, van der Heijde D, Keller C, Hafstroem I (2003) The clinical efficacy of low dose prednisolone in addition to DMARDs in early, active RA: an open randomized study. Arthritis Rheum 48(9 (Suppl.)):S652-S653
7. van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW (2002) Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 136(1):1-12
8. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B et al (1994) Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96(2):115-123
9. Buttgereit F (2003) Current issues of basic and clinical glucocorticoid research. Clin Exp Rheumatol 21(2): 145-147
10. Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J et al (2002) Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61(8): 718-722
11. Buttgereit F, Brand MD, Burmester GR (1999) Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol 58(2):363-368
12. Fleischmann RM, Schechtman J, Bennett R, Handel ML, Burmester GR, Tesser J et al (2003) Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Arthritis Rheum 48(4):927-934
13. Weinblatt ME, Kremer JM, Coblyn JS, Maier AL, Helfgott SM, Morrell M et al (1999) Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 42(7): 1322-1328
14. Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ et al (1999) Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 130(6):478-486
15. Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A et al (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet 353(9149): 259-266
16. Thiele K, Buttgereit F, Huscher D, Zink A (2005) Current use of glucocorticoids in patients with rheumatoid arthritis in Germany. Arthritis Care Res 53 (in press)
17. Zink A, Listing J, Ziemer S, Zeidler H, for the German Collaborative Arthritis Centres (2001) Practice variation in the treatment of rheumatoid arthritis among German rheumatologists. J Rheumatol 28(10):2201-2208
18. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 46(2):328-346
19. Piper JM, Ray WA, Daugherty JR, Griffin MR (1991) Corticosteroid use and peptic ulcer disease: role of non-steroidal anti-inflammatory drugs. Ann Intern Med 114(9):735-740
20. Bijlsma JW, Boers M, Saag KG, Furst DE (2003) Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis 62(11):1033-1037
21. Ramsey-Goldman R (2002) Missed opportunities in physician management of glucocorticoid-induced osteoporosis? Arthritis Rheum 46(12): 3115-3120
22. Patschan D, Loddenkemper K, Buttgereit F (2001) Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29(6):498-505
23. Manolagas SC, Weinstein RS (1999) New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14(7): 1061-1066
24. Canalis E, Giustina A (2001) Glucocorticoid-induced osteoporosis: summary of a workshop. J Clin Endocrinol Metab 86(12):5681-5685
25. Reid IR (2000) Glucocorticoid-induced osteoporosis. Baillieres Best Pract Res Clin Endocrinol Metab 14(2):279-298
26. Sambrook PN (2000) Corticosteroid osteoporosis: practical implications of recent trials. J Bone Miner Res 15(9):1645-1649
27. Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-induced Osteoporosis. Arthritis Rheum 44(7):1496-1503